Previous 1 2 3 4 5
MDS Offers to Acquire Molecular Devices for US$615 Million in Major Expansion of MDS Sciex Business
MDS Inc. , and Molecular Devices Corporation today announced they have signed a definitive agreement for MDS to acquire Molecular Devices, a leading provider of high-performance measurement tools for high content screening, cellular analysis and biochemical testing, in a US$615 million cash transaction. (Mon, 29 Jan 2007 13:00:00 GMT)
MDS Offers to Acquire Molecular Devices for US$615 Million in Major Expansion of MDS Sciex Business
MDS Inc. , and Molecular Devices Corporation today announced they have signed a definitive agreement pursuant to which MDS will acquire Molecular Devices, a leading provider of high-performance measurement tools for high content screening, cellular analysis and biochemical testing, in a US$615 million cash transaction. (Mon, 29 Jan 2007 13:00:00 GMT)
Online Application Database From Franek Technologies Allows Scientists and Managers to Protect Mission Critical ...
Steadfast to its mission to be an industry resource to the laboratory and instrumentation community, Franek Technologies, Inc., the leader in certified Category III-3 Laboratory Battery Backup Power Protection Systems, continues to enhance its online database, which now contains over 1,500 instruments from more than 100 OEMs. (Mon, 29 Jan 2007 13:00:00 GMT)
MDS Offers to Acquire Molecular Devices for US$615 Million in Major Expansion of MDS Sciex Business
SUNNYVALE, Calif. and TORONTO, Jan. 29 /PRNewswire-FirstCall/ -- MDS Inc. ( Nachrichten ) (NYSE: MDZ; TSX: MDS), and Molecular Devices Corporation ( Nachrichten ) today announced they have signed a definitive agreement pursuant to which MDS will acquire Molecular Devices, a leading provider of high-performance measurement tools for high content screening, cellular analysis and biochemical ... (Mon, 29 Jan 2007 13:16:20 GMT)
Novel Laboratory Technique Nudges Genes Into Activity
A new technique that employs RNA, a tiny chemical cousin of DNA, to turn on genes could lead to therapeutics for conditions in which nudging a gene awake would help alleviate disease, researchers at UT Southwestern Medical Center say. (Mon, 29 Jan 2007 14:08:25 GMT)
Cholera pathogen reveals how bacteria generate energy to live
Troy, N.Y. -- Researchers at Rensselaer Polytechnic Institute have discovered new details about how bacteria generate energy to live. In two recently published papers, the scientists add key specifics to the molecular mechanism behind the pathogen that causes cholera. (Mon, 29 Jan 2007 14:09:26 GMT)
DSM publishes DNA sequence of Aspergillus niger genome in 'Nature Biotechnology'
DSM is publishing a paper in the February 2007 issue of the renowned scientific journal "Nature Biotechnology" announcing the release of the DNA sequence of the fungus Aspergillus niger. (Mon, 29 Jan 2007 14:13:20 GMT)
Vanderbilt-Ingram Cancer Center Receives $6.5 Million Grant to Study Tumor Environment
Like a seed needs soil to grow and flourish, a tumor relies on its environment to grow and spread in the body -- something the Vanderbilt-Ingram Cancer Center will be exploring more closely with the help of a new $6.5 million grant from the National Cancer Institute (NCI). (Mon, 29 Jan 2007 14:25:13 GMT)
Gordon proposes medical district
Phoenix hopes to add another layer to its downtown-revitalization effort in the form of a mile-long biomedical district that would allow multiple hospitals, specialty clinics and research institutions to expand or locate in the city's core. (Mon, 29 Jan 2007 15:17:07 GMT)
JDRF-funded researchers discover protein that causes blood vessel leakage and swelling in eyes
New York, NY– January 29, 2007 -- The Juvenile Diabetes Research Foundation, the world’s leading charitable funder of type 1 diabetes research, announced today that JDRF-funded researchers have identified a group of proteins that may play critical roles in causing blood vessel leakage in the eyes of people with two forms of diabetic retinopathy. (Mon, 29 Jan 2007 15:42:32 GMT)
Genes May Tell A Lot About The Secret Lives Of Bees
Despite the fact that bees are one of the most beneficial insects in the world, much of their behavior remains a mystery -- even to the apiculturists who tend them. To better understand such fundamental processes as reproduction, and cope with problems such as bee mites and diseases, scientists are at work on a state-of-the-art genomics resource. (Mon, 29 Jan 2007 16:08:05 GMT)
Protein Found That Causes Blood Vessel Leakage And Swelling With Diabetic Retinopathy
Joslin researchers discover protein that causes blood vessel leakage and swelling in eyes with diabetic retinopathy. Discovery one day could lead to new treatments for eye diseases and brain swelling caused by head injury, stroke and other conditions. (Mon, 29 Jan 2007 17:07:34 GMT)
Mayo Clinic, U of Minnesota Open $22M Genomics Facility
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 29 Jan 2007 21:00:07 GMT)
Researchers Create New Method for Uncovering Natural Products from Mystery ‘Orphan Genes`
Microorganisms have a proven track record for producing powerful molecules useful in antibiotics, as anticancer agents, and in treating human diseases. (Mon, 29 Jan 2007 21:39:43 GMT)
Genes behind animal growth discovered
How many genes influence a complex trait, like weight, height or body type? And why does the answer matter? (Mon, 29 Jan 2007 22:13:38 GMT)
UALR Faculty, Staff Exceed Goal for Campus Campaign
University of Arkansas at Little Rock faculty and staff reached the 2006 campus campaign's fund-raising goal of 45 percent participation, campaign coordinator Laura Dobbins says. (Mon, 29 Jan 2007 22:46:17 GMT)
Science-Speak 101
By John Russell, The Indianapolis Star Jan. 29--Dr. Richard Wagner spends his days thinking about how to develop vaccines in algae to prevent the spread of disease in animals. (Mon, 29 Jan 2007 23:15:51 GMT)
DNA test is for the dogs
DNA testing is known for its value in solving crimes, pinpointing diseases and establishing paternity, and now a new purpose — revealing the genetic makeup of mixed-breed dogs. (Tue, 30 Jan 2007 00:45:51 GMT)
New Nanotechnology Able To Examine Single Molecules, Aiding In Determining Gene Expression
A new nanotechnology that can examine single molecules in order to determine gene expression, paving the way for scientists to more accurately examine single cancer cells, has been developed by an interdisciplinary team of researchers at UCLA's California Nanosystems Institute (CNSI), New York University's Courant Institute of Mathematical Sciences, and Veeco Instruments, a nanotechnology ... (Tue, 30 Jan 2007 02:01:28 GMT)
UNL supercomputers help research projects
HAL. Big Mac. PrairieFire. Welcome to the supercomputer. On Thursday night, roughly 15 students from the University of Nebraska-Lincoln gathered near the front entrance to Avery Hall. Supercomputer Statistics - Estimated replacement cost for PrairieFire and Red, separately: $500,000 - PrairieFire's storage capacity is about nine terabytes, or 9,216 gigabytes. (Tue, 30 Jan 2007 06:26:48 GMT)
Uncovering Natural Products From Mystery 'Orphan Genes'
Microorganisms have a proven track record for producing powerful molecules useful in antibiotics, as anticancer agents, and in treating human diseases. (Tue, 30 Jan 2007 11:08:55 GMT)
Third Wave and Stratagene Resolve Patent Litigation; Companies Agree to Process to Resolve Future Disputes
MADISON, Wisc. & LA JOLLA, Calif.----Third Wave Technologies, Inc. and Stratagene Corporation today announced that they have reached an out-of-court settlement regarding the matter litigated in U.S. (Tue, 30 Jan 2007 11:30:00 GMT)
STRICTLY COMMERCIAL
Each Tuesday the Business section includes news of commercial real estate transactions involving the nine-county Bay Area. To have transactions listed, send e-mail to realdeals@sfchronicle.com. - -- -- SALES Apartment deals... (Tue, 30 Jan 2007 11:49:42 GMT)
Leading Healthcare Companies Join in Major Research and Development Effort to Prevent Heart Attack and Stroke
WALTHAM, Mass.----BG Medicine announced today that together with Merck & Co., AstraZeneca, Royal Philips Electronics and Humana it has formed the High-Risk Plaque Initiative to research and advance the understanding, recognition and management of high-risk plaque, the primary underlying cause of heart attacks. (Tue, 30 Jan 2007 12:00:00 GMT)
DSM publishes fungus genome to help R&D into enzymes
30/01/2007 - Netherlands-based DSM has announced the publication of the full genome for the fungus Aspergillus niger used to produce a range of enzyme and other compounds for the food industry. (Tue, 30 Jan 2007 12:04:39 GMT)
St. Jude Children's Research Hospital Licenses MetaCore From GeneGo
GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that St. Jude Children's Research Hospital has licensed its data mining suite MetaCore. (Tue, 30 Jan 2007 13:00:00 GMT)
Arla Foods and Integrated Genomics to Sequence and Analyze Lactic Acid Bacterium
Integrated Genomics, Inc. , a leading provider of microbial gene sequencing and analysis services, has signed an agreement with Arla Foods in Sweden and Denmark to sequence, and annotate the genome of a dairy lactic acid bacterium. (Tue, 30 Jan 2007 13:00:00 GMT)
Gulf Coast Consortium Members to Use Invitrogen's Stealth siRNA Libraries in Screening Centers
CARLSBAD, Calif. & HOUSTON----Invitrogen Corporation , a provider of essential life science technologies for disease research and drug discovery, today announced it has formed a strategic scientific relationship with researchers from Baylor College of Medicine and The University of Texas at Houston, part of the John S. (Tue, 30 Jan 2007 13:00:00 GMT)
Third Wave and Stratagene Resolve Patent Litigation; Companies Agree to Process to Resolve Future Disputes
Third Wave Technologies, Inc. (NASDAQ:TWTI) and Stratagene Corporation (NASDAQ:STGN) today announced that they have reached an out-of-court settlement regarding the matter litigated in U.S. District Court in Wisconsin in September 2005 and appealed to the Federal Circuit in Washington, D.C. (Tue, 30 Jan 2007 13:18:56 GMT)
Breakthrough in Diabetes-Related Blindness Made
Researchers have identified a group of proteins that may play critical roles in causing blood vessel leakage in the eyes of people with two forms of diabetic retinopathy. (Tue, 30 Jan 2007 13:19:37 GMT)
Strategic Diagnostics Announces Successful Expansion of Proprietary Antibody Technology into the Japanese Life Science ...
NEWARK, Del.----Strategic Diagnostics Inc. - today announced that its partnership with the Oriental Yeast Company is meeting commercialization targets for its Genomic Antibodies service offering within the Japanese Life Science industry. (Tue, 30 Jan 2007 13:22:00 GMT)
New Release Genedata Expressionist Strengthens Cross-Omics Technology Integration For Biomarker Discovery
Swiss-based computational biology firm Genedata announces the release of Genedata Expressionist Pro 4.0, a fully scalable data management and analysis platform for biomarker discovery (Tue, 30 Jan 2007 13:29:23 GMT)
Biotech challenge set for 2007
BioTech SYSTEM, a consortium of the Solano, Yolo and Sacramento counties with a mission to promote biotech training and educational programs across Northern California, has launched Teen Biotech Challenge 2007. In this program, high school biology students are challenged to demonstrate biotechnology's impact on society by looking at topics such as stem-cell research, biofuels, personalized (Tue, 30 Jan 2007 14:37:01 GMT)
Company To Offer Genetic Test For Dogs
Soon you won't have to guess about your pooch's lineage. (Tue, 30 Jan 2007 14:56:37 GMT)
Strategic Diagnostics Announces Successful Expansion of Proprietary Antibody Technology into the Japanese Life Science ...
Strategic Diagnostics Inc. (Nasdaq:SDIX) - today announced that its partnership with the Oriental Yeast Company is meeting commercialization targets for its Genomic Antibodies™ service offering within the Japanese Life Science industry. (Tue, 30 Jan 2007 16:17:17 GMT)
LifeSpan BioSciences Enters into Agreement With Roche for Expanded DrugTarget(TM) Localization Database
LifeSpan BioSciences, Inc., a leading antibody company specializing in immunohistochemistry and antibodies to drug target proteins, today announced a multi-year agreement with Roche for a subscription to LifeSpan's DrugTarget DatabaseTM. (Tue, 30 Jan 2007 16:19:17 GMT)
DSM publishes fungus genome to help R&D into enzymes
1/30/2007 - Netherlands-based DSM has announced the publication of the full genome for the fungus Aspergillus niger used to produce a range of enzymes and other compounds for the food industry. (Tue, 30 Jan 2007 16:21:41 GMT)
Biotech challenge set for Yolo students
BioTech SYSTEM, a consortium of the Solano, Yolo and Sacramento counties with a mission to promote biotech training and educational programs across Northern California, has launched Teen Biotech Challenge 2007. (Tue, 30 Jan 2007 16:58:02 GMT)
Gulf Coast Chemical Genomics Consortium to Use Invitrogen siRNA Screening Tech for Disease Studies
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 30 Jan 2007 20:21:12 GMT)
Biosite Incorporated Announces 2006 Fourth Quarter and Annual Results
Biosite Incorporated today reported financial results for the fourth quarter and full year 2006 and discussed its revenue and earnings per share guidance for 2007. (Tue, 30 Jan 2007 21:02:00 GMT)
Applied Biosystems to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device ...
FOSTER CITY, Calif.----Applied Biosystems Group , an Applera Corporation business, will webcast its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Tuesday, February 6, 2007. (Tue, 30 Jan 2007 21:05:00 GMT)
UA and Banner consider creation of high-rise teaching hospital
A hospital in the sky? University of Arizona and Banner Health officials are looking at high-rise facilities for a proposed teaching hospital and cancer center in downtown Phoenix. (Tue, 30 Jan 2007 23:36:34 GMT)
Education & Employment - at the Colleges
Community College of Rhode Island Lecture: Nationally renowned scientist, author and Brown University Prof. Kenneth R. Miller will speak at the college on God, Darwin and Design: America's New Battle Over Evolution on Tuesday, Feb. (Wed, 31 Jan 2007 01:13:32 GMT)
Breakthrough in diabetes-related blindness made
Researchers have identified a group of proteins that may play critical roles in causing blood vessel leakage in the eyes of people with two forms of diabetic retinopathy. (Wed, 31 Jan 2007 02:23:35 GMT)
Celestial Labs to enter capital market with IPO of Rs 30 cr
Celestial Labs Ltd, a Hyderabad-based ISO 9001-2000 certified company, is entering the capital market with a public issue of Rs 30 crore to part finance its new projects. The company is setting up project for manufacturing industrial biotech (enzymes) like alpha amylase and alkaline protease. (Wed, 31 Jan 2007 02:54:43 GMT)
Eating According to Your Genome
The emerging field of nutrigenomics is starting to yield some DNA-based diet tips, says nutrition scientist Jose Ordovas. (Wed, 31 Jan 2007 05:09:27 GMT)
Ciphergen: Partnering with the Big Boys
Joseph Citarrella submits: I personally know little or nothing about where most companies in the biotechnology or pharmaceutical industries are headed and likely would never recommend buying any company within these industries. (Wed, 31 Jan 2007 05:18:14 GMT)
New hospitals may be high-rises
A hospital in the sky? University of Arizona and Banner Health officials are looking at high-rise facilities for a proposed teaching hospital and cancer center in downtown Phoenix. (Wed, 31 Jan 2007 05:19:19 GMT)
Many Young People Who Died Suddenly And Inexplicably Had Genetic Heart Defects, Study Finds
In 49 young people who died suddenly and inexplicably at an average age of 14, conventional autopsies found no cause of death. But when Mayo Clinic researchers conducted a sophisticated form of postmortem genetic testing -- known as a molecular autopsy -- they found that more than one-third died due to potentially heritable genetic defects that impair the heart's rhythm center. (Wed, 31 Jan 2007 11:09:14 GMT)
Cargill and MMI Genomics Launch Tru-Marbling(TM) and Tru-Tenderness(TM) DNA Based Selection Products
NASHVILLE, Tenn.----Cargill and MMI Genomics, Inc. today announced the launch of two new breeding tools for the cattle industry: Tru-Marbling and Tru-Tenderness. These products are the result of a collaborative research and product development project spanning more than four years between Cargill and MMI Genomics, a wholly-owned subsidiary of MetaMorphix, Inc. (Wed, 31 Jan 2007 12:00:00 GMT)
CONVENTIONAL AND PROTEOMIC TECHNOLOGIES FOR THE DETECTION OF EARLY STAGE MALIGNANCIES: Markers for Ovarian Cancer
By Lee, Catherine J; Ariztia, Edgardo V; Fishman, David A Our understanding of the tumor microenvironment continues to evolve and allows for the identification of biomarkers that should detect the presence of early stage malignancies. (Wed, 31 Jan 2007 13:16:36 GMT)
Rhode Island Biotechnology Company Develops Tularemia Vaccine
PROVIDENCE, R.I.----EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has developed a promising tularemia vaccine candidate (TuliVax) that confers protective immunity. (Wed, 31 Jan 2007 13:30:00 GMT)
Texas Institute for Genomic Medicine Will Supply CIC bioGUNE Research Centre in Spain with Knockout Research Mice over ...
HOUSTON----The Texas Institute for Genomic Medicine has entered into an agreement with the Centro de Investigacion Cooperativa en Biociencias in Spain to supply genetically altered mice over the next three years for use in collaborative research focused on understanding liver function and finding a cure for liver diseases. (Wed, 31 Jan 2007 15:00:00 GMT)
New Technique Assesses Effects Of Multiple Copies Of Genes On Disease Risk
Scientists at Washington University School of Medicine in St. Louis and the biotech firm Nimblegen Systems Inc. have successfully tested a technique for identifying newly recognized DNA variations that may influence disease risk. (Wed, 31 Jan 2007 15:07:44 GMT)
OGT, Sanger to Co-develop Prenatal Microarray for Genetic Disorders
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 31 Jan 2007 15:21:02 GMT)
Legislation would fund genomics research
ST. PAUL -- Medical genomics research being conducted through the partnership of Mayo Clinic and the University of Minnesota would receive continuous, ongoing funding o (Wed, 31 Jan 2007 15:45:44 GMT)
Discovery of Protein That Causes Blood Vessel Leakage And Swelling In Eyes
The Juvenile Diabetes Research Foundation, the world's leading charitable funder of type 1 diabetes research, announced today that JDRF-funded researchers have identified a group of proteins that may play critical roles in causing blood vessel leakage in the eyes of people with two forms of diabetic retinopathy.These findings result from years of research conducted by Edward Feener, Ph.D. [click ... (Wed, 31 Jan 2007 17:01:35 GMT)
Farmers discard BtGM Variety
The sustained and no-holds-barred campaign by Indian farmers against the "backdoor and sly" move to introduce the genetically modified GM rice variety into the country, has resulted in the farmers in parts of Haryana and Tamil Nadu destroying the trial plots of GM rice. (Wed, 31 Jan 2007 18:25:33 GMT)
Heller Presents Nanofabrication Advances Using Nanogen Technology at Lab Automation Conference
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, announced today that Michael J. Heller has presented results demonstrating nanofabrication applications of the company's NanoChip® technology at the LabAutomation 2007 conference in Palm Springs, Calif. (Wed, 31 Jan 2007 18:30:00 GMT)
How Bacteria Generate Energy To Live revealed by Cholera Pathogen
Researchers at Rensselaer Polytechnic Institute have discovered new details about how bacteria generate energy to live. In two recently published papers, the scientists add key specifics to the molecular mechanism behind the pathogen that causes cholera. [click link for full article] (Wed, 31 Jan 2007 19:02:06 GMT)
X PRIZE to Draw Top Innovators, Entrepreneurs to Gala as Mission to Benefit Humanity Expands
LOS ANGELES--X PRIZE will launch a major fundraising campaign to support an expanded mission that will include a dozen new X PRIZEs to be announced in the next few years. (Wed, 31 Jan 2007 19:18:14 GMT)
Texas Institute for Genomic Medicine Will Supply CIC bioGUNE Research Centre in Spain With Knockout Research Mice Over ...
The Texas Institute for Genomic Medicine (TIGM) (Wed, 31 Jan 2007 19:19:15 GMT)
Cargill Launches New DNA-Based Cattle-Breeding Tools
A collaborative research and product-development project between Cargill and MMI Genomics, a wholly owned subsidiary of Beltsville, Md.-based MetaMorphix, has resulted in the launch of two new breeding tools for the cattle industry. (Wed, 31 Jan 2007 21:08:56 GMT)
IN THIS ISSUE
A recent study by John Harrington, “The Impact of Low Price Magazines,” argues that magazines priced under $2 can’t be profitable for mass market magazine wholesalers under the current terms of sale. (Wed, 31 Jan 2007 21:53:47 GMT)
Toward Development Of An "Eggshell-And-Yolk" Anticancer Nanomedicine
Scientists in Hong Kong are reporting synthesis and early laboratory tests of a new nanostructure that they believe may lead to the design of an anticancer nanomedicine. In a study scheduled for publication in the Feb. 21 issue of the weekly Journal of the American Chemical Society, Bing Xu and colleagues describe the structure as an eggshell nanocrystal. [click link for full article] (Wed, 31 Jan 2007 23:01:35 GMT)
Illumina to Present at the Annual Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference
SAN DIEGO----Illumina, Inc. announced today that Jay Flatley, President and Chief Executive Officer and Christian Henry, Senior Vice President and Chief Financial Officer, will present an overview of the Company's commercial and product development activity at the upcoming Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference in New York. (Wed, 31 Jan 2007 23:25:00 GMT)
Solanacae Genome Project Gets $1.8 Million NSF Grant
Cornell and the Boyce Thompson Institute for Plant Research at Cornell have received a $1.8 million NSF grant to continue leading an international effort to sequence the tomato genome and to create a database of genomic sequences and information on the tomato and related plants. (Wed, 31 Jan 2007 23:26:11 GMT)
Previous 1 2 3 4 5
